In a positive development, more than half of Minnesota’s seniors are now up to date with COVID-19 vaccinations, providing increased protection for this vulnerable population.
This milestone comes at a time when COVID-19 hospitalizations have doubled in the state over the past two months, reaching 535 on Tuesday.
Vulnerable Age Group Still Bears Majority of Deaths
While the increase in COVID-19 cases is notable, it is no longer categorized as a public health emergency. Notably, the current hospitalization numbers remain below the state’s single-day record of 1,864 in November 2020, a time before vaccines were widely available.
Seniors aged 65 and older, who are more susceptible to severe illness, still account for a significant percentage of COVID-related deaths in the state. Recent data indicates that 93% of the 468 COVID-19 deaths since October 1 are in this age group, contributing to 83% of the state’s 15,505 overall COVID deaths.
Despite the progress in senior vaccinations, there are regional variations in vaccination rates, with lower levels observed in the northwest. Health officials stress the importance of continuing vaccination efforts, emphasizing that boosters remain effective against current viral variants.
Read more: CDC Director Optimistic As RSV Peaks Amidst Rising COVID-19 And Flu Cases
Minnesota Faces Rising COVID-19 Cases
The recent rise in COVID-19 cases is not solely attributed to the JN.1 coronavirus variant but is believed to be influenced by seasonal indoor gatherings and lower vaccine uptake. In addition to the COVID-19 surge, Minnesota is also experiencing an increase in seasonal influenza levels, with 225 flu-related hospitalizations reported this week.
While COVID-19 infections had declined at the beginning of 2023, the trend reversed in mid-summer. The University of Minnesota’s wastewater tracking indicates gradual increases in viral levels.
To combat the rising cases, health officials are urging more people to seek COVID-19 boosters. Nearly 1 million Minnesotans have received boosters since the federal government recommended new formulations to protect against emerging variants. Currently, only 18% of the population is considered up to date with COVID-19 vaccinations.
CentraCare, based in St. Cloud, reports a record demand for Paxlovid, an antiviral drug that can reduce COVID-19 severity. The surge in prescriptions is attributed to patients testing positive for COVID-19 at home and seeking treatment.
Many individuals opting for the antiviral are vaccinated but did not pursue boosters, expressing concerns about their level of protection. The increased demand underscores the importance of ongoing efforts to boost vaccination rates and address emerging health challenges.
Read more: WHO’s Alert And The Emergence Of JN.1 Amidst The Recent COVID-19 Surge
